Ben Venue was required by court to comply with good manufacturing standards set. The local unit of German pharmaceutical firm Boehringer Ingelheim, Ben Venue Laboratories Inc.
Tags: Boehringer Ingelheim
Asthma Inhaler Costs to Be Slashed as Drugmakers Introduce $35 Price Cap
Many Americans will benefit from reduced inhaler costs as AstraZeneca and Boehringer Ingelheim implement new out-of-pocket price caps of $35 per month, reflecting a move towards more affordable asthma medication following years of public concern over high prices.
Actavis, Sanofi among bidders for Omega Pharma
Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV [COUCKO.UL], Bloomberg reported, citing people familiar with the matter.
Accelrys picks up Irish software firm Qumas in $50M takeover deal
California, US-based software developing company Accelrys has acquired Ireland-based software business Qumas in a deal valued at $50 million to expand its products expansion and client base.
Boehringer subsidiary hires Bank of America to explore sale of injectable drugs business
Ben Venue Laboratories, a subsidiary of German Boehringer Ingelheim in the US, has engaged Bank of American Merill Lynch to advise it on a proposed sale of its sterile injectable drugs business.
Latest News
1
